Electra Therapeutics, Inc. · NASDAQ:ETRA
Redmile Group, LLC reported a 8.70% stake in Electra Therapeutics, Inc. (Schedule 13G)
Event Sep 21, 2026 · Filed Sep 28, 2026
Redmile Group, LLC reported a 8.70% stake in Electra Therapeutics, Inc., 5,462,881 shares, as a passive investor on Sep 21, 2026. Filed Sep 28, 2026 (Schedule 13G).
- Stake
- 8.70%
- Shares
- 5,462,881
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Redmile Group, LLC | 8.70% | 5,462,881 |
| Jeremy C. Green | 8.70% | 5,462,881 |
| Redmile Biopharma Investments II, L.P. | 7.60% | 4,796,215 |
Source
Related
- Electra Therapeutics, Inc.
- Redmile Group, LLC
- Electra Therapeutics, Inc. shareholders
- Schedule 13G · LSP 7 Cooperatief U.A. · Sep 28, 2026
- Schedule 13D · Orbimed Advisors LLC · Sep 25, 2026
- Form 4 · Gordon Carl L · Sep 23, 2026
- Form 4 · Orbimed Capital Gp VII LLC · Sep 23, 2026
- Form 4 · Koe Gary S. · Sep 21, 2026